Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma

Yu Wang,Tongjun Song,Kai Li,Hao Liu,Yan Han,Tao Xu,Fengjun Cao,Yong Li,Yuandong Yu
DOI: https://doi.org/10.1186/s12957-022-02698-9
2022-07-16
World Journal of Surgical Oncology
Abstract:Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor of the digestive tract with a poor prognosis. The tumor microenvironment (TME) is mainly composed of tumor cells, stromal cells, and immune cells and plays an important role in ESCC development. There are substantial differences in tumor purity among different parts of ESCC tissues, consisting of distinct immune and stromal cells and variations in the status of hypoxia. Thus, prognostic models of ESCC based on bioinformatic analysis of tumor tissues are unreliable.
oncology,surgery
What problem does this paper attempt to address?